IP Library › Assignment 052456/0343
Patent Assignment
Reel/Frame 052456/0343

Security Interest

Recorded: 2020-04-21 Pages: 12
Assignor
PHASEBIO PHARMACEUTICALS, INC.
Executed: 2020-03-19
Assignee
SILICON VALLEY BANK, AS AGENT
3003 TASMAN DRIVE, SANTA CLARA, CALIFORNIA, 95054
Covered Properties (13)
Multimeric Elp Fusion Constructs
Patent: 7,709,227 →
Application: 11/620,034 →
Publication: US 2008/0032400
Modified Vasoactive Intestinal Peptides
Patent: 9,029,505 →
Application: 12/857,103 →
Publication: US 2011/0178017
Formulations of Active Agents for Sustained Release
Application: 14/099,590 →
Publication: US 2014/0171370
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Patent: 9,561,262 →
Application: 14/124,612 →
Publication: US 2015/0111829
Modified Vasoactive Intestinal Peptides
Patent: 9,700,598 →
Application: 14/681,597 →
Publication: US 2016/0220642
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Application: 15/276,151 →
Publication: US 2017/0072021
Methods and Compositions for Treating Cystic Fibrosis
Application: 15/308,626 →
Publication: US 2017/0182130
A Method for Administering a Sustained Release Formulation
Patent: 9,919,032 →
Application: 15/355,386 →
Publication: US 2017/0136092
Elp Fusion Proteins for Controlled and Sustained Release
Application: 15/527,985 →
Publication: US 2019/0015523
Methods and Compositions for Treating Muscle Disease and Disorders
Application: 15/546,037 →
Publication: US 2018/0333467
Modified Vasoactive Intestinal Peptides
Application: 15/621,320 →
Publication: US 2018/0008677
Elp Fusion Proteins for Controlled and Sustained Release
Application: 16/099,261 →
Publication: US 2019/0218274
Metalloenzyme Inhibitor Compounds
Application: 16/124,846 →
Publication: US 2019/0008861
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 23, 2007
From: DAGHER, SUZANNE
To: PHASE BIOSCIENCE, INC.
Reel/Frame 018802/0961 →
Change of Name Mar 26, 2010
From: PHASE BIOSCIENCE, INC.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 024143/0049 →
Assignment of Assignor's Interest Jun 30, 2011
From: SADEGHI, HOMAYOUN; TURNER, ANDREW; DAGHER, SUZANNE
To: PHASBIO PHARMACEUTICALS, INC.
Reel/Frame 026530/0468 →
Assignment of Assignor's Interest Mar 10, 2014
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0075 →
Assignment of Assignor's Interest Mar 10, 2014
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0090 →
Assignment of Assignor's Interest Nov 23, 2015
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 037117/0277 →
Assignment of Assignor's Interest Feb 1, 2018
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER; GEORGOPOULOS, LYNNE
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 044795/0680 →
Assignment of Assignor's Interest Apr 4, 2018
From: ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 045434/0757 →
Assignment of Assignor's Interest Jun 15, 2018
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046099/0507 →
Assignment of Assignor's Interest Jun 15, 2018
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046097/0317 →
Assignment of Assignor's Interest Apr 4, 2019
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 048796/0907 →
Assignment of Assignor's Interest Apr 18, 2019
From: SPARKS, STEVEN; YATES, CHRISTOPHER M.; SHAVER, SAMMY R.; HOEKSTRA, WILLIAM J.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 048930/0474 →
Assignment of Assignor's Interest Apr 18, 2019
From: VIAMET PHARMACEUTICALS (NC), INC.
To: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
Reel/Frame 048930/0527 →
Change of Name May 2, 2019
From: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 049074/0397 →
Assignment of Assignor's Interest Jan 2, 2020
From: GEORGOPOULOS, LYNNE; ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051401/0327 →
Assignment of Assignor's Interest Feb 20, 2020
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051878/0894 →
Assignment of Assignor's Interest Feb 20, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051871/0854 →
Assignment of Assignor's Interest Feb 20, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051871/0800 →
Patent and Trademark Security Agreement Nov 12, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SFJ PHARMACEUTICALS X, LTD.
Reel/Frame 054401/0188 →
Security Interest Oct 10, 2022
From: PHASEBIO PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061367/0674 →
Security Interest Oct 31, 2022
From: PHASEBIO PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061601/0001 →
Release of Security Interest Jan 13, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 062376/0850 →
Assignment of Assignor's Interest Feb 14, 2023
From: PHASEBIO PHARMACEUTICALS, INC.
To: JI XING PHARMACEUTICALS HONG KONG LIMITED
Reel/Frame 062691/0373 →
Assignment of Assignor's Interest Mar 15, 2023
From: PHASEBIO PHARMACEUTICALS, INC.
To: IMMUNOFORGE CO., LTD.
Reel/Frame 062993/0313 →
Correction of Error in Assignee Address as Listed in Cover Sheet Previously Recorded at Reel/Frame 062691/0373 Jun 6, 2023
From: PHASEBIO PHARMACEUTICALS, INC.
To: JI XING PHARMACEUTICALS HONG KONG LIMITED
Reel/Frame 063873/0889 →